John Carroll, the founder and editor of biopharmaceutical news site Endpoints, writes about its future with the hiring of former Bloomberg News journalist Drew Armstrong as its executive editor.
Carroll writes, “This hasn’t been a quick hire, and while I often wished it had gone faster, I appreciate now more than ever the chance I had to get to know Drew before we all signed on the dotted line recently. The insights he’s offered on our business, his ideas for growth, his energy and purpose for creating Endpoints 2.0, and 3.0, have been a real learning experience.
“I expect to continue to learn from him. I certainly look forward to it.
“Some things aren’t going to change.
“Arsalan and I had a chance to renew some of those old vows with Drew. We’ll remain a steadfastly independent business publication. Insight and integrity are our guides. And now we’ll look for new ways to bring our brand of must-read journalism to other areas as well.
“You can expect to hear more about that — from Drew — before the year ends.”
Read more here.
